XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses:        
Research and development, net of tax credits $ 8,951 $ 4,853 $ 17,583 $ 8,556
General and administrative 3,372 1,032 5,555 2,108
Total operating expenses 12,323 5,885 23,138 10,664
Loss from operations (12,323) (5,885) (23,138) (10,664)
Other income (expense), net        
Realized and unrealized gain (loss) on foreign exchange 595 227 (1,136) 299
Change in fair value of Series A preferred share tranche obligation   (680)   (700)
Other expense (4) (1) (6) (3)
Total other income (expense), net 591 (454) (1,142) (404)
Loss before income taxes (11,732) (6,339) (24,280) (11,068)
Income tax expense (70) (20) (123) (129)
Net loss and comprehensive loss (11,802) (6,359) (24,403) (11,197)
Net loss attributable to common shareholders—basic and diluted $ (11,802) $ (6,359) $ (24,403) $ (11,197)
Net loss per share attributable to common shareholders—basic and diluted $ (2.45) $ (4.16) $ (7.56) $ (7.33)
Weighted-average common shares outstanding—basic and diluted 4,825,214 1,528,374 3,229,635 1,528,374